Literature DB >> 20604922

Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study.

Benjamin G Fincke1, Donald R Miller, Cindy L Christiansen, Robin S Turpin.   

Abstract

BACKGROUND: Diabetic foot infections are common, serious, and diverse. There is uncertainty about optimal antibiotic treatment, and probably substantial variation in practice. Our aim was to document whether this is the case: A finding that would raise questions about the comparative cost-effectiveness of different regimens and also open the possibility of examining costs and outcomes to determine which should be preferred.
METHODS: We used the Veterans Health Administration (VA) Diabetes Epidemiology Cohorts (DEpiC) database to conduct a retrospective observational study of hospitalized patients with diabetic foot infections. DEpiC contains computerized VA and Medicare patient-level data for VA patients with diabetes since 1998, including demographics, ICD-9-CM diagnostic codes, antibiotics prescribed, and VA facility. We identified all patients with ICD-9-CM codes for cellulitis/abscess of the foot and then sub-grouped them according to whether they had cellulitis/abscess plus codes for gangrene, osteomyelitis, skin ulcer, or none of these. For each facility, we determined: 1) The proportion of patients treated with an antibiotic and the initial route of administration; 2) The first antibiotic regimen prescribed for each patient, defined as treatment with the same antibiotic, or combination of antibiotics, for at least 5 continuous days; and 3) The antibacterial spectrum of the first regimen.
RESULTS: We identified 3,792 patients with cellulitis/abscess of the foot either alone (16.4%), or with ulcer (32.6%), osteomyelitis (19.0%) or gangrene (32.0%). Antibiotics were prescribed for 98.9%. At least 5 continuous days of treatment with an unchanged regimen of one or more antibiotics was prescribed for 59.3%. The means and (ranges) across facilities of the three most common regimens were: 16.4%, (22.8%); 15.7%, (36.1%); and 10.8%, (50.5%). The range of variation across facilities proved substantially greater than that across the different categories of foot infection. We found similar variation in the spectrum of the antibiotic regimen.
CONCLUSIONS: The large variations in regimen appear to reflect differences in facility practice styles rather than case mix. It is unlikely that all regimens are equally cost-effective. Our methods make possible evaluation of many regimens across many facilities, and can be applied in further studies to determine which antibiotic regimens should be preferred.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20604922      PMCID: PMC2914722          DOI: 10.1186/1472-6963-10-193

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  32 in total

1.  Determinants of prescribing of second-choice antibiotics for upper and lower respiratory tract episodes in Dutch general practice.

Authors:  Huug J van Duijn; Marijke M Kuyvenhoven; François G Schellevis; Theo J M Verheij
Journal:  J Antimicrob Chemother       Date:  2005-06-16       Impact factor: 5.790

2.  Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population.

Authors:  S Berman; P J Byrns; J Bondy; P J Smith; D Lezotte
Journal:  Pediatrics       Date:  1997-10       Impact factor: 7.124

3.  Diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

4.  Comparison and validity of procedures coded With ICD-9-CM and ICD-10-CA/CCI.

Authors:  Carolyn De Coster; Bing Li; Hude Quan
Journal:  Med Care       Date:  2008-06       Impact factor: 2.983

5.  Improving the statistical approach to health care provider profiling.

Authors:  C L Christiansen; C N Morris
Journal:  Ann Intern Med       Date:  1997-10-15       Impact factor: 25.391

6.  Antibiotic treatment of children with sore throat.

Authors:  Jeffrey A Linder; David W Bates; Grace M Lee; Jonathan A Finkelstein
Journal:  JAMA       Date:  2005-11-09       Impact factor: 56.272

7.  Guidelines for diabetic foot care: recommendations endorsed by the Diabetes Committee of the American Orthopaedic Foot and Ankle Society.

Authors:  Michael S Pinzur; Mark P Slovenkai; Elly Trepman; Naomi N Shields
Journal:  Foot Ankle Int       Date:  2005-01       Impact factor: 2.827

Review 8.  Antibiotic selection for diabetic foot infections: a review.

Authors:  B A Cunha
Journal:  J Foot Ankle Surg       Date:  2000 Jul-Aug       Impact factor: 1.286

9.  A classification of diabetic foot infections using ICD-9-CM codes: application to a large computerized medical database.

Authors:  Benjamin G Fincke; Donald R Miller; Robin Turpin
Journal:  BMC Health Serv Res       Date:  2010-07-06       Impact factor: 2.655

10.  Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.

Authors:  M L Grayson; G W Gibbons; G M Habershaw; D V Freeman; F B Pomposelli; B I Rosenblum; E Levin; A W Karchmer
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

View more
  5 in total

1.  Gas gangrene and osteomyelitis of the foot in a diabetic patient treated with tea tree oil.

Authors:  Derek R Cooney; Norma L Cooney
Journal:  Int J Emerg Med       Date:  2011-04-14

2.  Infections in patients with diabetes mellitus: A review of pathogenesis.

Authors:  Juliana Casqueiro; Janine Casqueiro; Cresio Alves
Journal:  Indian J Endocrinol Metab       Date:  2012-03

3.  Microbiological Etiology and Treatment of Complicated Skin and Skin Structure Infections in Diabetic and Nondiabetic Patients in a Population-Based Study.

Authors:  Iiro H Jääskeläinen; Lars Hagberg; Erik Forsblom; Asko Järvinen
Journal:  Open Forum Infect Dis       Date:  2017-03-10       Impact factor: 3.835

Review 4.  The system of care for the diabetic foot: objectives, outcomes, and opportunities.

Authors:  Neal R Barshes; Meena Sigireddi; James S Wrobel; Archana Mahankali; Jeffrey M Robbins; Panos Kougias; David G Armstrong
Journal:  Diabet Foot Ankle       Date:  2013-10-10

5.  Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration.

Authors:  Brigid M Wilson; Mary T Bessesen; Gheorghe Doros; Sheldon T Brown; Elie Saade; John Hermos; Federico Perez; Marion Skalweit; Brad Spellberg; Robert A Bonomo
Journal:  JAMA Netw Open       Date:  2019-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.